Literature DB >> 8963399

Asymptomatic membranous obstruction of the inferior vena cava forming intrahepatic collateral pathways.

M Kamba1, S Ochi, H Ochi, S Maruyama, H Sato, Y Suto.   

Abstract

Intrahepatic and/or extrahepatic collateral pathways result from the membranous obstruction of the inferior vena cava. These collaterals are usually insufficient to prevent Budd-Chiari syndrome. We reprot an unusual case of asymptomatic membranous obstruction of the inferior vena cava in which marked intrahepatic collateral pathways were formed. Although the inferior vena cava terminated above the orifice of the right hepatic vein, the middle and left hepatic veins were patent above the membrane, without narrowing. Blood from the inferior vena cava drained into the right atrium via the intrahepatic collaterals between the right and middle hepatic veins without resistance.

Entities:  

Mesh:

Year:  1995        PMID: 8963399     DOI: 10.1007/bf02349648

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  10 in total

1.  Unusual hepatic venous drainage in inferior vena cava obstruction: demonstration by MRI.

Authors:  C Guinet; D Mathieu; J M Métreau; D Dhumeaux; N Vasile
Journal:  AJR Am J Roentgenol       Date:  1986-09       Impact factor: 3.959

2.  The Budd-Chiari syndrome: a review.

Authors:  F B Murphy; H V Steinberg; G T Shires; L G Martin; M E Bernardino
Journal:  AJR Am J Roentgenol       Date:  1986-07       Impact factor: 3.959

3.  Membranous obstruction of the hepatic portion of the inferior vena cava. Surgical correction and etiological study.

Authors:  M Hirooka; C Kimura
Journal:  Arch Surg       Date:  1970-06

4.  Transhepatic collateral pathway due to vena caval obstruction.

Authors:  E Salomonowitz; W R Castaneda-Zuniga; J L Bass; G Lund; A H Cragg; K Amplatz
Journal:  AJR Am J Roentgenol       Date:  1984-06       Impact factor: 3.959

5.  Angiographic abnormalities in partial Budd-Chiari syndrome.

Authors:  R Maguire; J L Doppman
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

6.  Collateral channels and histopathology in hepatic vein occlusion.

Authors:  K J Cho; K R Geisinger; J J Shields; M E Forrest
Journal:  AJR Am J Roentgenol       Date:  1982-10       Impact factor: 3.959

7.  Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa.

Authors:  I W Simson
Journal:  Gastroenterology       Date:  1982-02       Impact factor: 22.682

8.  Membranous obstruction of the inferior vena cava: comparison of findings at sonography, CT, and venography.

Authors:  J H Lim; J H Park; Y H Auh
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

9.  Magnetic resonance imaging diagnosis of Budd-Chiari syndrome.

Authors:  A C Friedman; P Ramchandani; M Black; D F Caroline; P D Radecki; P Heeger
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

10.  Intrahepatic venous collaterals forming via the inferior right hepatic vein in 3 patients with obstruction of the inferior vena cava.

Authors:  K Takayasu; N Moriyama; Y Muramatsu; H Goto; Y Shima; T Yamada; M Makuuchi; S Yamasaki; H Hasegawa; K Hojo
Journal:  Radiology       Date:  1985-02       Impact factor: 11.105

  10 in total
  3 in total

1.  Budd-Chiari syndrome: two cases with different courses.

Authors:  Shinjiro Inomata; Yasuaki Takeyama; Takashi Tanaka; Shu-Ichi Ueda; Daisuke Morihara; Shinya Nishizawa; Teruo Matsumoto; Akira Anan; Hirokatsu Nishimura; Makoto Irie; Kaoru Iwata; Satoshi Shakado; Tetsuro Sohda; Hideyuki Higashihara; Masatoshi Okazaki; Shotaro Sakisaka
Journal:  Case Rep Gastroenterol       Date:  2008-08-15

2.  Computed tomography angiography manifestations of collateral circulations in Budd-Chiari syndrome.

Authors:  Shi-Feng Cai; Yong-Hao Gai; Qing-Wei Liu
Journal:  Exp Ther Med       Date:  2014-12-10       Impact factor: 2.447

3.  Diagnosis of the cavo-hepato-atrial pathway in Budd-Chiari syndrome by ultrasonography.

Authors:  Yong-Hao Gai; Shi-Feng Cai; Hui-Li Fan; Qing-Wei Liu
Journal:  Exp Ther Med       Date:  2014-07-04       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.